Shanting Lin

Dr. Shanting Lin


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2024 in Food Research International
Verified
Journal Article
Closed access
SLShanting Lin
Shanting Lin
JLJun Li
Jun Li
XHXiao Hu
Xiao Hu
SCShengjun Chen
Shengjun Chen
HHHui Huang
Hui Huang
ZLZhenxing Li
Zhenxing Li

14 October 2026 in Foods
Verified
Journal Article
Open access
PDF file
YLYong-Qian Liang
Yong-Qian Liang
SLShanting Lin
Shanting Lin
Shengjun ChenShengjun Chen
Shengjun Chen
Yongqiang ZhaoYongqiang Zhao
Yongqiang Zhao
HHHui Huang
Hui Huang
XHXiao Hu
Xiao Hu
This study developed a dietary polysaccharide-stabilized peptide-Fe2+ composite beverage to address iron deficiency anemia (IDA). Through single-factor and orthogonal experiments, the formulation was optimized (cranberry/blueberry concentrate ratio 4:6, 600 mL/L; FA-COS@Peptide-Fe2+@PTry-CMC 200 mL/L; vitamin C 1.5 g/L; pectin 0.06 g/L), and processing parameters were determined (homogenization: 12,000 rpm, 20 min; sterilization: 95 °C, 15 min). Storage stability was optimal at 4 °C in dark conditions. Under the optimal processing conditions, the beverage attained a maximum suspension stability of 17.74% and the optimized formulation achieved a highest sensory score of 94.0 (out of 100). In vivo experiments showed that the beverage dose-dependently restored hematological parameters (e.g., HGB, SI, TIBC) and tissue iron levels, alleviated intestinal oxidative stress and inflammatory markers in IDA mice, while repairing colonic mucosal damage without adverse effects. The beverage demonstrated high iron-supplementing efficacy and excellent biosafety, offering a promising strategy for IDA intervention.